Skip to main content
. 2022 Nov 27;14(23):5047. doi: 10.3390/nu14235047

Table 6.

Univariate and multivariate analysis for prognostic factors for disease-free survival.

Univariable Analysis Multivariate Analysis
Before NT After NT
Variables GLIM-Malnutrition GLIM-Malnutrition + Low VAT GLIM-Malnutrition GLIM-Malnutrition + Low VAT
HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value
Age (≥65) 1.132 (0.693–1.850) 0.62
Sex (female) 1.298 (0.777–2.168) 0.319
CCI (≥3) 0.955 (0.576–1.585) 0.859
NT regimen (NCRT) 1.197 (0.675–2.122) 0.538
ypstage (III/0-II) 6.249 (3.846–10.152) <0.001 5.394 (3.281–8.868) <0.001 5.647 (3.452–9.239) <0.001 5.394 (3.245–8.967) <0.001 5.481 (3.309–9.081) <0.001
Pathologic response (CAP 3/0-2) 2.335 (1.454–3.752) <0.001
Before NT
BMI (≥23) 0.638 (0.398–1.024) 0.063
NLR (>3) 2.140 (1.296–3.532) 0.003
Serum PA (<200) 1.486 (0.895–2.465) 0.126
GLIM-malnutrition 2.749 (1.709–4.423) <0.001 2.038 (1.252–3.319) 0.004
GLIM-malnutrition + low VAT 2.823 (1.757–4.536) <0.001 2.312 (1.429–3.741) 0.001
After NT
 BMI (≥23) 0.890 (0.554–1.431) 0.631
 NLR (>3) 1.206 (0.670–2.170) 0.532
 Serum PA (<200) 2.195 (1.336–3.607) 0.002
 GLIM-malnutrition 2.587 (1.609–4.159) <0.001 1.662 (1.009–2.736) 0.046
 GLIM-malnutrition + low VAT 2.695 (1.637–4.437) <0.001 1.701 (1.012–2.859) 0.045

Abbreviations: NT, neoadjuvant treatment; GLIM, the Global Leadership Initiative on Malnutrition; VAT, visceral adipose tissue; CCI, Charlson comorbidity index; NCRT, neoadjuvant chemoradiotherapy; ypstage, post-neoadjuvant therapy stage; CAP, tumor regression grading of College of American Pathologists; BMI, body mass index; NLR, Neutrophil-lymphocyte ratio; Serum PA, Serum prealbumin; HR, hazard ratio; CI, confidence interval. Note: One of the malnutrition diagnoses (GLIM-malnutrition or GLIM-malnutrition + low VAT) was incorporated into Multivariate analysis. - The bold values represent statistical significance, p < 0.05.